Clinical Trial Update: Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the accuracy of indocyanine green fluorescence imaging to assist Giant cell tumor of bone surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Conditions: Giant Cell Tumor of Bone | Phase 4 | Status: RECRUITING